Conduit Pharmaceuticals Inc. share price logo

Conduit Pharmaceuticals Inc. Share Price

NASDAQ: CDT

Small Cap

$2.54

-0.21

(-7.72%)

Live

as on

Conduit Pharmaceuticals Inc. Stock Performance

as on April 28, 2026 at 3:07 am IST

  • Day's Low

    Day's High

    $2.45
    $2.83
    downward going graph

    3.54%

    Downside

    11.42%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.60
    $1,754.40
    downward going graph

    -2.42%

    Downside

    68970.87%

    Upside

    downward going graph

Conduit Pharmaceuticals Inc. share price movements today

Previous Close
$2.75
Open
$2.75
Volume
133.1K
Day's Low - High
$2.45 - $2.83
52 Week Low - High
$2.60 - $1,754.40

Conduit Pharmaceuticals Inc. Historical Returns

1 Month Return
-64.97 %
3 Month Return
-90.03 %
1 Year Return
-99.84 %
3 Year Return
0 %
5 Year Return
0 %

Conduit Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Conduit Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.4M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Conduit Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Conduit Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Conduit Pharmaceuticals Inc. image
Conduit Pharmaceuticals Inc.
NA$13.4MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.8B116.23%131.78.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.5B99.64%28.132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.4BNA121.785.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.5B52.82%18.1131.41%

Stock Returns calculator for Conduit Pharmaceuticals Inc. Stock including INR - Dollar returns

The Conduit Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Conduit Pharmaceuticals Inc. investment value today

Current value as on today

₹166

Returns

-₹99,834

(-99.83%)

Returns from Conduit Pharmaceuticals Inc. Stock

-₹99,849 (-99.85%)

Dollar Impact

₹16 (+0.02%)

Conduit Pharmaceuticals Inc. Stock’s Investor Sentiment and Interest

Search interest for Conduit Pharmaceuticals Inc. Stock has increased by 233% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:233% versus previous 30 day period

Conduit Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
535
-1,345
654
1,076
624
671
698
2,715
Gross Profit
-
-
201
-695
0
0
0
0
0
0
Operating Income
0
0
-2
-3
-5
-3
-3
-4
-7
-21
EBITDA
2
1
-3
-5
-6
0
-4
-5
-6
-20
Interest Expense
0
0
0
0
0
0
0
0
0
46
Depreciation
-
-
-
-
0
0
0
0
-1
2
Income Before Tax
2
1
-3
-5
-6
-2
-4
-6
-7
-21
Income Tax Expense
0
0
-8
-11
-60
0
-10
-5
0
29
Net Income
2
1
-3
-5
-6
-2
-4
-6
-7
-21
Net Profit Margin
0.00%
0.00%
-0.67%
0.40%
-0.99%
-0.22%
-0.76%
-0.90%
-1.02%
-0.79%

Conduit Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
922
2,715
Gross Profit
-
-
-
0
1,031
Operating Income
-3
-3
-5
-15
315
EBITDA
-3
-4
3
-15
371
Interest Expense
-
-
0
1
46
Depreciation
-
-
-
0
2
Income Before Tax
-3
-4
2
-17
266
Income Tax Expense
0
0
0
-29
29
Net Income
-3
-4
0
-17
237
Net Profit Margin
0.00%
0.00%
0.00%
-1.93%
8.75%

Conduit Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
1
-3
-5
-6
-2
51
-6
56
134
Operating Cash Flow
-4
-2
-1
-1
-3
7
-2
105
-4
Investing Cash Flow
0
0
0
0
0
-24
0
-39
0
Financing Cash Flow
0
0
0
1
4
-96
3
-54
1
Change in Cash
-4
-2
-1
0
0
-111
1
12
-2

Conduit Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
0
-17
237
Operating Cash Flow
-2
-7
-9
354
Investing Cash Flow
0
0
0
-128
Financing Cash Flow
2
10
6
-217
Change in Cash
0
4
-3
19

Insights on Conduit Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 24.7% return, outperforming this stock by 124.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CDT stock has moved down by -18.0%

About Conduit Pharmaceuticals Inc.

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
OrganisationConduit Pharmaceuticals Inc.
Headquarters4581 Tamiami Trail North, Naples, FL, United States, 34103
IndustryBiotechnology
CEODr. Andrew Regan
E-voting on sharesClick here to vote

Key Management of Conduit Pharmaceuticals Inc.

Name

Title

Dr. Andrew Regan

Founder, CEO & Director

Mr. James Bligh

Co-Founder, CFO & Director

Dr. Joanne M. Holland

Chief Scientific Officer

FAQs

What is Conduit Pharmaceuticals Inc. share price today?

Conduit Pharmaceuticals Inc. share price today is $2.54 as on . Conduit Pharmaceuticals Inc. share today touched a day high of $2.83 and a low of $2.45.

What is the 52 week high and 52 week low for Conduit Pharmaceuticals Inc. share?

Conduit Pharmaceuticals Inc. share touched a 52 week high of $1,754.4 on and a 52 week low of $2.6 on . Conduit Pharmaceuticals Inc. stock price today i.e. is trending at $2.54,which is 99.86% down from its 52 week high and -2.36% up from its 52 week low.

What is Conduit Pharmaceuticals Inc.'s market capitalisation today?

Conduit Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Conduit Pharmaceuticals Inc. Stock (CDT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Conduit Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Conduit Pharmaceuticals Inc. Shares that will get you 0.5906 shares as per Conduit Pharmaceuticals Inc. share price of $2.54 per share as on April 27, 2026 at 9:37 pm IST.

What is the minimum amount required to buy Conduit Pharmaceuticals Inc. Stock (CDT) from India?

Indian investors can start investing in Conduit Pharmaceuticals Inc. (CDT) shares with as little as ₹94.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.90 in Conduit Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Conduit Pharmaceuticals Inc. share’s latest price of $2.54 as on April 27, 2026 at 9:37 pm IST, you will get 3.9370 shares of Conduit Pharmaceuticals Inc.. Learn more about fractional shares .